IDEXX Q4 Earnings and Revenues Top Estimates, Stock Up in Pre-Market
IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2024 earnings per share (EPS) of $2.62, up 12.9% year over year. The figure surpassed the Zacks Consensus Estimate by 9.1%. Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 ...
Stocks were falling Monday but came off sharp lows as President Donald Trump’s delay to tariffs on Mexico for a month had ...
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...
IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...
Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...
IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...
Key Takeaways IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback